Ming Ji
- Molecular Biology top 10%
- Oncology top 10%
- Immunology top 10%
- Organic Chemistry top 10%
- Cancer Research
- Topics
- PI3K/AKT/mTOR signaling in cancer (11 papers)PARP inhibition in cancer therapy (9 papers)Cancer therapeutics and mechanisms (6 papers)
- Cited by
- ImmunologyOncologyMolecular Biology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaScientific Reports
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Ming Ji
71 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 105
- Molecular Biology 692
- Oncology 316
- Immunology 260
- Organic Chemistry 252
- Cancer Research 137
Countries citing papers authored by Ming Ji
This map shows the geographic impact of Ming Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Ji more than expected).
Fields of papers citing papers by Ming Ji
This network shows the impact of papers produced by Ming Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Ji. The network helps show where Ming Ji may publish in the future.
Co-authorship network of co-authors of Ming Ji
This figure shows the co-authorship network connecting the top 25 collaborators of Ming Ji. A scholar is included among the top collaborators of Ming Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Ji. Ming Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 8 | |
| 6 | 7 | |
| 7 | 13 | |
| 8 | 20 | |
| 9 | 16 | |
| 10 | 0 | |
| 11 | 13 | |
| 12 | 66 | |
| 13 | 28 | |
| 14 | 48 | |
| 15 | 6 | |
| 16 | 144 | |
| 17 | 35 | |
| 18 | Analysis of EB Virus antibodies levels and probability of suffering from nasopharyngeal carinoma in first-degree relatives of nasopharyngeal carinoma patients | 1 |
| 19 | Analysis of the risk factors in early rebleeding after endoscopic variceal ligation | 5 |
| 20 | 18 |
About Ming Ji
Ming Ji is a scholar working on Oncology, Immunology and Molecular Biology, having authored 73 papers that have together received 1.4k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (11 papers), PARP inhibition in cancer therapy (9 papers) and Cancer therapeutics and mechanisms (6 papers). The work is most often cited by research in Immunology (260 citations), Oncology (316 citations) and Molecular Biology (692 citations). Ming Ji has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Xiaoguang Chen, Nina Xue, Jing Jin, Fangfang Lai, 敬 島津, Bailing Xu, Jie Zhou, Heng Xu, Songwen Lin and Ran Cao. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.